Clinical Trials Browser

OTHER × Ovarian Neoplasms × Ketorolac × Clear all

NCT02470299 2025-05-22

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Phase NA Completed

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms